- Home
- METC vs ARVN Comparison
METC vs ARVN Comparison
Compare METC & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- METC
- ARVN
- Stock Information
- Founded
- METC 2015
- ARVN 2015
- Country
- METC United States
- ARVN United States
- Employees
- METC N/A
- ARVN N/A
- Industry
- METC Coal Mining
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- METC Energy
- ARVN Health Care
- Exchange
- METC Nasdaq
- ARVN Nasdaq
- Market Cap
- METC 514.2M
- ARVN 456.2M
- IPO Year
- METC 2017
- ARVN 2018
- Fundamental
- Price
- METC $10.97
- ARVN $7.44
- Analyst Decision
- METC Strong Buy
- ARVN Buy
- Analyst Count
- METC 3
- ARVN 21
- Target Price
- METC $13.67
- ARVN $20.53
- AVG Volume (30 Days)
- METC 776.4K
- ARVN 2.3M
- Earning Date
- METC 08-06-2025
- ARVN 07-29-2025
- Dividend Yield
- METC 4.36%
- ARVN N/A
- EPS Growth
- METC N/A
- ARVN N/A
- EPS
- METC N/A
- ARVN N/A
- Revenue
- METC $628,275,000.00
- ARVN $426,900,000.00
- Revenue This Year
- METC N/A
- ARVN $4.26
- Revenue Next Year
- METC $25.50
- ARVN N/A
- P/E Ratio
- METC N/A
- ARVN N/A
- Revenue Growth
- METC N/A
- ARVN 498.74
- 52 Week Low
- METC $5.90
- ARVN $5.90
- 52 Week High
- METC $14.15
- ARVN $34.11
- Technical
- Relative Strength Index (RSI)
- METC 61.28
- ARVN 51.46
- Support Level
- METC $10.68
- ARVN $7.12
- Resistance Level
- METC $12.10
- ARVN $7.85
- Average True Range (ATR)
- METC 0.75
- ARVN 0.43
- MACD
- METC 0.16
- ARVN 0.05
- Stochastic Oscillator
- METC 68.52
- ARVN 48.05
About METC Ramaco Resources Inc.
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.